[
  {
    "title": "FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight Management, a Powerful New Option for the Treatment of Obesity or Overweight with Weight-Related Medical Problems",
    "link": "https://news.google.com/read/CBMiuwFBVV95cUxQdkFHTVNFUTh5Sm5MWm1OSEN1V0p4eXVQMC14dFd0b1ItV1MtTVBhSHF1eEZiOUFhRnVKZXpuYVBKOUZVZlRTVU16Q2tCWW5Ia0lSSEZleTJFLV91c1BIMmdZNHNXdUQ4cVFlZHlBWjc5c1RCMTBRRFQ5VGVpTmN6VW9sUVJFU21hNk9FWXBiczdObS1qajFaMWs1b1dGcFpaYnpmNWhtMkxjNkFFTXBrbTNtamkzaEtuckZr?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2023-11-08T08:00:00.000Z",
    "time": "Nov 8, 2023",
    "articleType": "regular"
  },
  {
    "title": "Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease",
    "link": "https://news.google.com/read/CBMivwFBVV95cUxQSzVBWkVzVE9scE92MWVnZVRYY3BicmNEZk16QVN0ZkhiaXFLT29pZkdmcVh6Sy1FT1dGbi05a3oxbkphUmlQcGxWZ0t6czl6b0RWNGp4WFlzeDJodzhaeU5sMUQ1eHdKWU43WEV1cjI1REhIU1ZPQWRRb3B2bDE1ckpDZU4wUTQyd19oZjdDcjdERWdlT1hOUEVsaTZWNTNuYXlvcGJRay1halVCQjVLMFQwQnIwcWhEUUR6cmNqcw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-07-02T07:00:00.000Z",
    "time": "Jul 2",
    "articleType": "regular"
  },
  {
    "title": "Lilly's tirzepatide successful in phase 3 study showing benefit in adults with heart failure with preserved ejection fraction and obesity",
    "link": "https://news.google.com/read/CBMivgFBVV95cUxNSXZfZ2tncXRvYUczakVZalp0aWM1VE1KTUF5XzNOZl9DRFBoSWdyTmtkMzRVSENIYVVXX1JLRWYyVFdWRU01NGpjQXZQMEJWWEhIY3hpNDJxVzFLQkREYTJLMXpCVFFhb3JHMzY4S2wyTlBfTUxfbWFTbW9TYnJNeWVkZjF0a2VMY1hUQ1g5Y2JjUk1WTGF6M095N3lkMzdORWxlRGQwQUdjaVNkVHpQZGM0N09obHNSZnFGYjFB?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-08-01T07:00:00.000Z",
    "time": "10 days ago",
    "articleType": "regular"
  },
  {
    "title": "An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro® and Zepbound®",
    "link": "https://news.google.com/read/CBMiwAFBVV95cUxNVGxCVXFmOGNZWXAycUhVSjJKV0h4V3VQcjZnTlpyUV9MdmQxdy1lWU4xN2NmVmJ0Mlo3UDlHbVM3Nm9sZnNjZzdQQ01fa0tkdmpLanNaMnluQU5MVnZHOHd2blRKSGpkb3JBbmZYcml0YV9XYkJCR0dMWk9id0RtQ3ZDYnJuS3E0bkQ1U0IxVVhzNzZKQzB5MDY2c2s5WjJYanV6ZnFEcTZJM0R6eHNkNWVmbURRenhaTUs0TGxJdTI?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-06-20T07:00:00.000Z",
    "time": "Jun 20",
    "articleType": "regular"
  },
  {
    "title": "Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum | Eli Lilly and Company",
    "link": "https://news.google.com/read/CBMiwAFBVV95cUxOUkdKS0htNXc5S3dNUHJCenZuek9yNGR0QURta0x2WVNGTWp1NGItNERhZUUzMXlCc2lrT09Vb2NheVA4Vmtmc0V1X1k4VUVYdVFQUmJadmJPQVk4bDNKZmM1ZHpnZlduSVR3NXJYcHMzRW1NT2QtX0Y3SzlsT0xNX0NKRURXMEQxeU1oVEVXeERuaU90V3FRTVBueVZZbGJPTWdteGxkYVdqeld4VFUtMUdyZXhaNTI4TGU1Q0ZSbWw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-04-30T07:00:00.000Z",
    "time": "Apr 30",
    "articleType": "regular"
  },
  {
    "title": "Lilly to expand injectable manufacturing capacity with planned $2.5 billion site in Germany | Eli Lilly and Company",
    "link": "https://news.google.com/read/CBMiuwFBVV95cUxNV3R5RU9HdGxuVVdxR2ljbFpzZFNKM2JTakxpdWZrNTNRcU1uengzLWF4MEYycXhQSFFCQ25USVNSWjJ3S2d6bVpzWFZ2elJoMkFTMTZhMV9BR29RVWFjb3hQVnF4U1RxdURHa3BpcjRmUWliOWZzRDNRM2dCU2FPRjk5SXZVZldXNGV0WXNyZmdqdEpRdW5fWGVMZ0lXbUFhZ0p3QkVydTFiNkdJRy1lM0tqRnRTSkFHNC04?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2023-11-17T08:00:00.000Z",
    "time": "Nov 17, 2023",
    "articleType": "regular"
  },
  {
    "title": "Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria | Eli Lilly and Company",
    "link": "https://news.google.com/read/CBMiwAFBVV95cUxNOW1MbUxqVW5QRV9RYTNqdjIySGZ3OEVtVHdtX3FDcTdrSmVqSXFYNFlkUlQyWXlqSEJKMHQtR0RHUnR6NWZTUTQ0R2Z5bXJtVnMwY0ZOaTl6LWpBODYtNXpIcHN4RkcxcTdick9SeG1kbERsajlvRWRldlhiMjV5N0xSVkR6a0ZZUXJRV1pKeGJ2WkVVY3FGdFJPTVh5YzkwMzk2Y3FOZGFaanZ6aTM0V0M5NFpudFMtTXdUTlR5ekk?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-06-25T07:00:00.000Z",
    "time": "Jun 25",
    "articleType": "regular"
  },
  {
    "title": "Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines | Eli Lilly and Company",
    "link": "https://news.google.com/read/CBMiuwFBVV95cUxOZWJmR2JmOWtSaEJ1c09zOGJ5NVlkeWFEVHl4Y2FKdkI0ajN3OGNDVGV5MENSWDdCZ21pUk1WWWpDVUZ0RWhVTkJpQWlmcGkyNXlCVlVxeTdMYWkzRzB4S1k2N0l0bEdCS3U2SDZZWHgtaWUyUURnajZkX2N3M0daV25VcDNxeVg2QjY4SFRVWFpsT2lMcWxwQlBaeEtBQlo4YlhuRnhyaWlfcmp5MDhESmtTeFRWYnU1a0Fn?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-05-24T07:00:00.000Z",
    "time": "May 24",
    "articleType": "regular"
  },
  {
    "title": "Lilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue Guidance by $3 Billion",
    "link": "https://news.google.com/read/CBMixAFBVV95cUxOcFFEajJ0UkFRdWs1NDVLdUhHYkhGUmJCUklXMmdhdXlxSnZsMDJ3dDdoeDR1WWFsZDN4WmMySDBvTmI5Uy1ULTBETjNYcFU0Q2wtY0JVWHQzWDU4eUFBdUhQcUhndFlsWU5pbzktNmplSEJ2Mk5GbUNNaFpnUGJpSkVDMjF3ZFFFTldWUzhMMjRKMklpbDR1SGJDS0J5d0ZyY2Q5a2lGOWVBcW0tNVBqRFl1N1VRLUs4M05adVBNVXhWN2Vv?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-08-08T10:52:30.000Z",
    "time": "3 days ago",
    "articleType": "regular"
  },
  {
    "title": "Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity",
    "link": "https://news.google.com/read/CBMivAFBVV95cUxPc0FYc2c1eEpJU29WakdMemFtcldIWUMwandidzJUaFlRZUNMekNkOHpxUV85ZXNiUUV4LTh1Vm1ERlJBZDlkQVpDTzJxUGNreEJLWjZVNGxsU1hCaUVaNG9feXUzbVpmOU0yQVJrMTlWZU1wRkpiTGljZjlfSXVvaHVGSzdJc3luOXdMQXU1YjltRS1vX3BSOGhNNGZ1M3VQVFRyMjAtQ2JyVUl4ak1QSGtHR2tKM25IR19sWg?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-04-17T07:00:00.000Z",
    "time": "Apr 17",
    "articleType": "regular"
  },
  {
    "title": "Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products",
    "link": "https://news.google.com/read/CBMiwwFBVV95cUxQdmRTV2Q1Wm9XSWFCWjFjOGp6WURYQ0l4TWlwc1J3Y3BIeU5qQ21OeFlWM0lUT1A4NzNITnRpbDRtYXlJQkFZY29aenpmSTJkdldCOTJEblRDUUZxT19GRVBPUFdkWVJUY0M0cG53SHRCQlBsSEhlVDcxakFYa0VRcVgwQi0wTFpVN3FGNGVqUlBSS01scHAzaExlaDViV0FHclZhdlR6V1FnbFhiQk45NUQzTkVfTDVsUEltNHhNYlVnZzQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-06-20T07:00:00.000Z",
    "time": "Jun 20",
    "articleType": "regular"
  },
  {
    "title": "Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks",
    "link": "https://news.google.com/read/CBMixAFBVV95cUxQYmNRRlR2VnpuRkh1WUtSWnBQOGtsUEhIc0lIdUR3d0dyRUxmeXZBRVhPTEpGOG55cW1fVjVWTWREUm5GMWZEN080b3ZTNllqWTBPS2pYTDF3NXBRcUZzc3pxYlNRcHVzYThsOFJIR0pLa1NIQzFVSHhETmNwZy10NDhaSDVTUEZRU2J4TDhZNGFpNXFCdURrZ2wxdnp2UVcwLWdpMjhrSHFqUm5FNXdpY1lDdXFHeTFVMmFrNzVhMjhKUG5D?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-06-08T07:00:00.000Z",
    "time": "Jun 8",
    "articleType": "regular"
  },
  {
    "title": "Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting",
    "link": "https://news.google.com/read/CBMixAFBVV95cUxPaDM2X3FIb0RZWVVjbzNPRkdoQ0tkaENpWWI0cjYzVlBIRkNBdTFlZkhHU3o4c09yTmJLQUQtY1RReXlFVWJIS3ppaG80RkRPVzRPTDk4cFcxMWFNSlhGSi1DNms1MkZlMkRUVWxVM1JxX1lmVUp6NXlQempyY0wzeVVCLWs3bElCb2toZERKWHJmOEY4cGNILXJxTmJ6OHZWb3dxaEs0eWFkbUR2cWFLeG5UdFFWZ2YwbHNyUmlrNTFvc2sx?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-06-01T07:00:00.000Z",
    "time": "Jun 1",
    "articleType": "regular"
  },
  {
    "title": "Lilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolution",
    "link": "https://news.google.com/read/CBMiwwFBVV95cUxQZlVxS0s4QS1Oa3E3Mmx3Zmh6aDNzMGRmdnlIcFZhTUY5eW1rc3UyRGpOYk92MnlxRGdFM3VFQVN6dE0yYUQ1VVBxRnhPZmNETkI3eEY0UnNRcjg0cGMwNjlEd3FWMVRveThfQXhaNERsR3QzaVNRRHZ1TXY0NU9VbkJXWDlJWmxqSnlTZmZQTldCTDRhZF9sT01DdmlMb0d0dzUwNnpCVFVsWmx6RU0wVmpsVjRQd0NqVUpvemZnaXRGc1U?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-06-21T07:00:00.000Z",
    "time": "Jun 21",
    "articleType": "regular"
  },
  {
    "title": "With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin",
    "link": "https://news.google.com/read/CBMiwAFBVV95cUxOZUJMRU5ISFdKR3l5SWM0UlBBbDVuTmxqNDZJckVnT1o5aHROTVBFejVVTzR6RnZkcmJxa0RVVHNueE9DSlJIb0tIX01CeGlPLTRsTWNxamF1anI0UGR3THdCLXY3b29GaXMyWXlQVlJuc2hfcnNWLUpsZ0c3X0NOdV9hcExNQXYyR1p4OC01dk5Wak9aVTlEQ1BqaU0tdmc5ckp3UjlzV1BvOGlxNWZ5RG5JZW4yUnRFMlh5ZnRtTHo?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-05-16T07:00:00.000Z",
    "time": "May 16",
    "articleType": "regular"
  },
  {
    "title": "U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab",
    "link": "https://news.google.com/read/CBMivAFBVV95cUxQZzFJX3psRGo1TlZOeU9KeFpFVmVDclRFVnpUSktfRTJUZW5Sdk9ja2UtMkpTbmU4Y29CUno5cGx3UURpN2RyS3o4R3dLc1l3eVQ3RU5uQVZfOUFELVRwS2ptdkp0dkNDVDRCTkY4czdzaklkcUx5S2RaVFJFZTNwckRPdk9Vcm0xeVdZdC1uMFNvVVlCdDl2QTdiOUxvZUlKaTVlaTlSZVJ6aDFZWG0yV19YLUZ1NUhvUVFGUA?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-03-08T08:00:00.000Z",
    "time": "Mar 8",
    "articleType": "regular"
  },
  {
    "title": "Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus Pharmaceuticals | Eli Lilly and Company",
    "link": "https://news.google.com/read/CBMiwAFBVV95cUxPT25QNEFVUy1tWTZCbkRNZlJSd2hNN0M5OGJBQTdweHJld3VXTjVMazFBcDNNUWcyX2VDTjJybFJVLU1XNjBQTlRvT1NpbVBEaEJhNFNNeWxJMVhoUzNXMWp5TzdYRklMdTlxczJwOWJqa0hhcTRPdlJSbGZ0Q2k4UW1XSXNCN2w1UkE3OFdqdWhUSEkyMkx5a21sY2E5SXJxTkdWYUJvbmZrTzV4UFlSd0dfOFZKVV9FRmFDWFJrTDM?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-04-22T14:04:10.000Z",
    "time": "Apr 22",
    "articleType": "regular"
  },
  {
    "title": "Lilly announces departure of Anat Ashkenazi, chief financial officer | Eli Lilly and Company",
    "link": "https://news.google.com/read/CBMixAFBVV95cUxNZGU5QU93aDlYU2RhOHYwcXRTZXNyTjkwdEtOdHJRX0dudWFyR0t4eERsTlhZLWFJdnJWcjhqZC1qSVpFVnRvTUwtWDhWMzB2N3UwTXlGWWM3R051UUJ0ZnNJXzNaSDhoa3M3ZlZRZ0N6VGVlQTZWZTVwRmdMOU5Pc3ZnVzJMd0E0bWRTZ1dyVElYRzRzNkhRSXFTTG42MWhkNFdNX3M4aUZIc3dDMXRLZkEyUGM1Y2Y4NDBEdlRTTjZPME5z?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-06-05T07:00:00.000Z",
    "time": "Jun 5",
    "articleType": "regular"
  },
  {
    "title": "Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease | Eli Lilly and Company",
    "link": "https://news.google.com/read/CBMivwFBVV95cUxQV3Bxb0JZdnJsbEFGX29jT1JKeG9FWTM5ZXdzOVFQQlhCMnpnNC0wRjQxeHJpSEZoeVR1VXpMcVc0cjN3N0VERVJyRDhaN0ZMX2x1WVRtOUpQM2tqMEZEVm0yOWduQkowbllJLUdwaFVyOThFSzcweU92UzNtekhMSWpPN013UUtPTjNGNXFiNVVWZ2xjV2xieVNUZklfcUU4blpYUTFFaGZyMTIzQUVTclA1ejc5VFl5dDBrRE04NA?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-07-08T07:00:00.000Z",
    "time": "Jul 8",
    "articleType": "regular"
  },
  {
    "title": "Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect™ | Eli Lilly and Company",
    "link": "https://news.google.com/read/CBMivwFBVV95cUxOWFg0NFNtRGp3ZVQwNzc0ejNHZV81VS00UXVpY25JU0dRc29jNW56STJJZWZ4MHNEd1ZIUjR5SHNMUGY3eTl2aFZ6MDZVeGdzME5NdG9hTEExU1NuYVVacXdINXFReWI5NTdsZTVYdmwtUmR5Njh4X1dGSjZnZktwU19HRmpqOHVNVDJBNWc4YUUtMV80VVZhRk5HZlk1dkZjM0lidFFYZDJ2VnZLU0NlcUFfOV9BMWNsOE55NjVmNA?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-01-04T08:00:00.000Z",
    "time": "Jan 4",
    "articleType": "regular"
  },
  {
    "title": "Research & Development",
    "link": "https://news.google.com/read/CBMiZ0FVX3lxTE5zWWNBRnlQMXluU0twRF9TNlpGOC1sYTl0UElmY25tZ0g1bXl0MzV6b0JLbG1ldHlBejlxXzE4WkE5WUs5b0UyTmgwa1FKeExzRDNEM3ZfQzkwTmhxbGVINElDdHNoazQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iL0NnNWljamh0VFZwQ09Xc3hWa3R3VFJDckFSaW5BaWdCTWdrTlFvaE9wZXBVTXdF=-w400-h224-p-df-rw",
    "source": "Eli Lilly",
    "datetime": "2024-07-18T16:08:15.000Z",
    "time": "Jul 18",
    "articleType": "regular"
  },
  {
    "title": "Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at the Association for Research in Otolaryngology 2024 MidWinter Meeting",
    "link": "https://news.google.com/read/CBMivAFBVV95cUxNY2NjdU1uMlQxejlBaVRTTG93bXZNTVVYSUtOT3p0TndSc0hCaDNuN2lNQWMyMDQzSlBXNHFMODZDWmpzTThrTGd0X2FId3llRE5EUlRzRFFiWXdTT3BhWEtiZWtGTlAyb3Joc2EtRF81VFFPTDBmYkdBcEk3WGoxUTIxZ28yakpObnozNHhkdEpXelBRWFNOZzJER3BnN3FOOWVvaGNRb1BiclJkbTN3RTRKREhoY2tjLU05MA?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-01-23T08:00:00.000Z",
    "time": "Jan 23",
    "articleType": "regular"
  },
  {
    "title": "Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases",
    "link": "https://news.google.com/read/CBMivgFBVV95cUxPNW1zSWhHQWtOVUtCZUxMaUFXeko5VEVDQ3ItQ0MzU3haMnE5VXZjang5SUFOODhJM0RSZnl2Tlh2bHVfVDgwR3BmbVNIS3VCcXRDQ19ual9aOVlxUXdNdEtZQTZ2OFNWc2tfUDFVbEtpSENOTDJsbEVJb1JSV2R6Z1JMZlRrc2NrSUdmdjFzSU50V0tydV9nczgxdjZpVV82WFBuYjVqV0IxaG9tb0Q3SVl6LUNRcjVDLXA4WU9B?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-05-29T07:00:00.000Z",
    "time": "May 29",
    "articleType": "regular"
  },
  {
    "title": "Mounjaro, Zepbound pour money into Eli Lilly, fueling a better-than-expected second quarter",
    "link": "https://news.google.com/read/CBMikAFBVV95cUxNTThBUWNMVjlVNGZKeXd2UGhkRHZzTE9CTEtwQlh0eW4yLU1keUlDUGpuTm1ydHpkQnp4OWdnY0t0UjQwU0Y2WG8yX1AySEZZczBCYXF0bnliV3F5d1UycUhYbEs5R1VhTnhVSkdidXpqSzN3VUw0LUowSGpUMVlOcFVlRlphMEF0ZEh5WmxGMXg?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWZWbmh1TVd4cGRGSjFOa1o1VFJDM0FSaVRBaWdCTWdhVmtJeXFOUVU=-w400-h224-p-df-rw",
    "source": "The Associated Press",
    "datetime": "2024-08-08T18:34:00.000Z",
    "time": "3 days ago",
    "articleType": "regular"
  },
  {
    "title": "Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues",
    "link": "https://news.google.com/read/CBMimAFBVV95cUxOcll3a3UwLUhsR1FxckFzbEhnbTkxcDFyMVZvQmswYm9hN01UZnprLWlCZU85UF9nZjZTdi1KZ0x1QV9TOWw4Z2NQZWRHbDNVVTl2cXVkNlJRcHlUNUtMS2VSZXZmUmVMakQwMWt3ZFdIaFdLcElaSmxZcXgwTnJ0NnRmOHNUb1RhblZ1TDJpS0JaeU4tb25Wdg?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXpZemxJYVdSR1NYUXdNbEpSVFJDM0FSaVRBaWdCTWdhVmtJeXFOUVU=-w400-h224-p-df-rw",
    "source": "The Associated Press",
    "datetime": "2024-04-30T07:00:00.000Z",
    "time": "Apr 30",
    "articleType": "regular"
  },
  {
    "title": "Lilly Reports Third-Quarter 2023 Financial Results, Highlights Strong Sales Growth and Business Development Activity",
    "link": "https://news.google.com/read/CBMiwAFBVV95cUxNUkhOVnFoWnhCQy1WQWhCbHJIMlVoc3lyMmxPWDNWYjVzOHJLUjZsZ1FxWWdleEpzLXc5VVJydFJQaVNycU95eEFKOWVUVzNzMzlMVTl5a1ZERWJydXZJb0VhUzlLVUU5RmZvbDBNM3I2eVlPcG92akgyZFpXbThSMlZfUEJwTTRBbVIzZE56Y3pXOE5FWUxYRVI1RmQwRXBzTVA3eHR6aGxLcDFHcFJvVmJNTV9OVVhfMlFXZmxDX1Y?hl=en-US&gl=US&ceid=US%3Aen",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2023-11-02T07:00:00.000Z",
    "time": "Nov 2, 2023",
    "articleType": "regular"
  },
  {
    "title": "Indiana Fever Announce Lilly as the Team's New Jersey Patch Partner",
    "link": "https://news.google.com/read/CBMimgFBVV95cUxPbnNBaldIOVNPTUtmZ3l3WkxFR3A1U0FXM0JqbEdSbjk5cTdOWlJUaVhBUEpueGV6ZTh5SV9DNTdPRXJCMjhqbWpXXzJDSGFLVGRIMUVUYkd4MTFBaXRHaWZBWmpzbXNrYVBCVXl1QnM0czFpdy1oMk9femJQQXBZd2ExUDlZYWdZRHFTZnI2em14clE3cG9iLUNn?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iL0NnNVBNR0kyYjNFNVJFUmFlR2xQVFJDWUFSak1BaWdCTWdtRkJZb0ZybVZ6cFFJ=-w400-h224-p-df-rw",
    "source": "Indiana Fever",
    "datetime": "2024-05-01T07:00:00.000Z",
    "time": "May 1",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly's weight loss drug tirzepatide gets approval in China",
    "link": "https://news.google.com/read/CBMiywFBVV95cUxNMHlfdTJLZEhQempHaVJqQUU3NEhsNGhlZDlHanJiVmRFdWl1RVdPbVFaSHg3Z3V2T2RaQWRSN25CTmRsYnpZVURYaVB3ZGVsbmJoRDRwS1RMQVgwaGtESGM3d1BvRjBVcnRxTmVBemRHemtMMTkzV1ljSjZOQ1BlRW1FenlzZ0w2blR4bFUxdWdwcV9rMy1za2VXaFYwTlJxcW5vZ1prUlk1LVZaTVVQS2JZWkpsSWhGaTltV1YyVlVFaVFLZGFqT3dWZw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXpXWFZrYkZONFR6RktZbFo0VFJDM0FSaVRBaWdCTWdhUlZKUUlKZ2c=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-07-19T07:00:00.000Z",
    "time": "Jul 19",
    "articleType": "regular"
  },
  {
    "title": "More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study",
    "link": "https://news.google.com/read/CBMiuAFBVV95cUxPLUVCSE1xa1NvcFo4eDQ4aHJoRFpwNk45aUNmYmtJUnpZaUsxMEdtZVZsQU9zQW1RVmdwbkpLVXdlV0VPemJ0NTdSanQ1ckMtdnJaV3M1Nk1ua3dYMDNGVjI2V01neVFWc2NEN1dBaHdXUVBwOXRZVnNGdGpsU3IyWXFoQzFSdHFLMEJxS0NudVVaN2FrZ0lEaGtOSUJRNzE1eGdzZ1NpWDhSLUl0ejVLRHFJMF9SUk0z?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-03-10T08:00:00.000Z",
    "time": "Mar 10",
    "articleType": "regular"
  },
  {
    "title": "More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failure",
    "link": "https://news.google.com/read/CBMixAFBVV95cUxOaUlEaUlLYmhvMjY2Y0pTQlFyX25STzFsNEtVTmdkc2dUczdfeHNRZG15VUN4RXNHLXJWNUVGMnRNNTJMUFBJX3BpOUs1eEVlVE5od0tmX3FveUE4YnJ0UGdvV3pFSzc2eDU2TkhGbEFiQzdSUzVsaTN0Z053OGpaTHRRc3hOWFNtZHlSQ09oV3h0MGpiV0pLb1RoeFhXX1V3STNwYUl2YWxQYU5yZkgxVUhmUFAtc0xLeDJmbWNjbkRpckJC?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-05-21T07:00:00.000Z",
    "time": "May 21",
    "articleType": "regular"
  },
  {
    "title": "Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement",
    "link": "https://news.google.com/read/CBMivAFBVV95cUxPdkRKNkxPYXNTdVdyWUkzZWZlRDB1SVRhemc3NkRaWTNCcGRJVTg2UzVCeHBOVDJLQnZQU3prVnlKWXd1OUcyYVliZDNQV2R1Ymg2azdmMjNIMDVmY0R5QzFaYUNyUjhHcGlxS2ZDS1dScHVucml3YXRSQTg1eWphT1VuZ3ZnRjQ4aGVrVDlXV1gwUlhENXFBSzhfNVlxTExQODlUSnl6R1hDc2h1RXZqY19kem8waE1hb0hIVw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-04-16T07:00:00.000Z",
    "time": "Apr 16",
    "articleType": "regular"
  },
  {
    "title": "Lilly Completes Acquisition of POINT Biopharma | Eli Lilly and Company",
    "link": "https://news.google.com/read/CBMiqAFBVV95cUxOdnc2MDRiTHk0NnU0NzBpdWZLalRYQWJoU1BaLWYtay1BVmpOQkxLTFQ0TERIaDVsa2FWTHctRnpuS1RDc1lYeFhkVXBUQTlDWHMzY2FTT3NmSEVkejNoQTlyY2R5aG1zdUIwbkZPUDdaV3AyV0RGekRuTXJCalhxSko1aWMzSE00Z184UEdLd2tZTlNnaFhHd2MyRjBpdEdjWXhETDZtSHA?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2023-12-27T08:00:00.000Z",
    "time": "Dec 27, 2023",
    "articleType": "regular"
  },
  {
    "title": "Zepbound™ (tirzepatide) is Now Available in U.S. Pharmacies for Adults Living with Obesity",
    "link": "https://news.google.com/read/CBMixAFBVV95cUxPcU9nb3YzOU50NHp0aGxSNE5MaGw2VmtsdXVBRUZ5U3gxUERyZkduLUswTFBVYkwzYmR0VTF1TUpHbnBBVVR2bG01UC1FbkNlRWlrSjdJTWJoaW5fRXlRWldYaFFhS3F0SEhfaXJfaXBWaWxXTjRlZW1XMnNndWtsWW1PUm5Od3ZDXzRKcTVOZjQyWVVVaHpmbEhZRXFkdm4wOUJoQVVHOTkzQ1dhOVpQV0ZVdjhsYVhHODJrdmkxa1FURHl6?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2023-12-05T12:39:58.000Z",
    "time": "Dec 5, 2023",
    "articleType": "regular"
  },
  {
    "title": "Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies",
    "link": "https://news.google.com/read/CBMiwwFBVV95cUxQTE84NENZM1JUZXVnbDBOdnJHWnVlT0NZRHlBMUx6QWVtankxajRWcnhmVDlBOF94MTJtbDNuZXNwb0I3aTYyRU40RVNxUk5EcDBJMEp3U09zNDREaGhSRnN3TnlXZUhYY2NaOHFLeVVtVFBrYUtfRks0RHdYbUlSTFZSQWhJOEVYMm1LUFBhVWtZZWxDS1FuRnpfMXJ5SndqdjVoM21uWER3NlFrSnJRY1NXNHRsaWp1S1Y2cGJDSVBBdGM?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2023-10-03T07:00:00.000Z",
    "time": "Oct 3, 2023",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar",
    "link": "https://news.google.com/read/CBMidkFVX3lxTE8wWHhnRnB3SkI2TFZmRzdXLUxlVEY4cDE5SHRyRzh6bEdzYVkwRnU0bHZHNC1qeWFSQWt1dEF5YnJFT01sM2Rkb0ZQZmhzVGVfdXUzOFEtSm5VeDEwNzE5U25GVnhkM0VoMVV4UjJ3cDNkNWFheHfSAXtBVV95cUxOYlY5M3lKUGxsbEZMa0JPYTU1Q00xU2tCYlVyY2dHWkM3c0F6bEhOeFhCdlNWX1RIY1JyV3RHVlBVQTMtVWpqUkx1ZjRGMnI5X01ZOGFEUTE5bVF4TFcwNFpXRnUtbmNJRGF2b01yS2VnM2U1TG5IN2taVmc?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNTNVbXROY0cwelRIRnNhMHhNVFJDb0FSaXNBaWdCTWdZUlZaWUlJZ2c=-w400-h224-p-df-rw",
    "source": "CNBC",
    "datetime": "2024-08-08T10:57:10.000Z",
    "time": "3 days ago",
    "articleType": "regular"
  },
  {
    "title": "Exclusive: US FDA finds new manufacturing lapses at Eli Lilly plant",
    "link": "https://news.google.com/read/CBMiwwFBVV95cUxPZlRPRkFmMFRFUHBMMXcwR2tiWXhIa3VjWWFPVHVmV3RlTWY4THFRWnVQZ3lmRGFOS0dTN3JrTkhoRUxaVTZGUWZnNGVya2owaFVxU3R4M20ydDB1X2JmV3FyYk1nU1pucDBya2IzR01mZ2xKZU5aaDFHR2FPRHBOTTlvbzBFREdGakllNDE1M09SUklnTldFeDl3Uk40UjZPZHFiWlFYa0tKanFaWDFNbmpYR3JkRUlfTGVsQk1PUFRhU2M?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNUxhRXR3TTNSaVIzRjBlaTB4VFJDM0FSaVRBaWdCTWdhUlU1UUlKZ2c=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-01-19T08:00:00.000Z",
    "time": "Jan 19",
    "articleType": "regular"
  },
  {
    "title": "Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity Care",
    "link": "https://news.google.com/read/CBMisgFBVV95cUxPZENIZy15S2E1cEpGdDVLTGpNWjRlWU51Tzl5OVF0eTlHS0lneHp4VlB0ZTdwOXVxQWhtYW9BbXNBSFdDTUhiVExEOVNXTG1HR0tHU1ZMRENtUjJqS2Y4dTBBNXpseVFHZ3AxYlA4ZS1vRUE5dlJRM3NmMzFjRDltb1VBV0tOdjhNN2IzNGtuczJvRXV1YTRIU1lRR0hTNWx6YmJfWV93MGdyOVBmbWFUa1ZR?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-03-07T08:00:00.000Z",
    "time": "Mar 7",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly's nationwide insulin pricing settlement called off",
    "link": "https://news.google.com/read/CBMisgFBVV95cUxPN01sTlBJdDA2RVNvcXlCOWk4MDlLS1dIOFhvaFRqdWNrMHZ3NGF6dk5nMHkyRmxINXZPNmRjNkR1cGRmSTZQNGVyTTJ5TTl0RHpXSFU2TE5SajJ4YkhPU3ZFUVdjeXEwVlR0WmQ0eDFfX3VlX3ZvMmJXcEticklOVVFzbTl6cWdrUG5qNjNmWnJ1SldlbUdwVHdzZlVMTjY1bjRUMlVlN1RPd292S3N4S0xR?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXFlbm95VnpKd1pGaDJaRTE2VFJDM0FSaVRBaWdCTWdZZE00T05YUUk=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-04-15T07:00:00.000Z",
    "time": "Apr 15",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro",
    "link": "https://news.google.com/read/CBMingFBVV95cUxPRlotbzRObDl3UlhIWEkxWHNNeE8xYjFjbS15bXBoVzBiSGN1RWI4SHNXWTBkUnV3MjZES2VfR0RXeUcyTzFERjUxdjJjcS1YTkNOdUJNZFY4b29ZSURsNmJkZVB4ZUtEV09KR0dVYW1zc3IxLTB1ZVIxWEZlanBlNGlyRUlDZ2puQXNBSEJWdnFKbnROa01uU2JmMzlEQQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXNRVTl4UkRkSGEyZHhNRTFDVFJDM0FSaVRBaWdCTWdhVmtJeXFOUVU=-w400-h224-p-df-rw",
    "source": "The Associated Press",
    "datetime": "2024-05-24T07:00:00.000Z",
    "time": "May 24",
    "articleType": "regular"
  },
  {
    "title": "Lilly Completes Acquisition of Versanis Bio | Eli Lilly and Company",
    "link": "https://news.google.com/read/CBMipAFBVV95cUxPdk1FMkMwcmk5MEplcXdfQ3p6MjZzT1VBTnRnRHlUbzB0MUFZVXl3MlpDZjF6Sm5Ec1VxOHRsMGZWb2tLSnhGeVYxQXoyOElkeGhJUkk5LTZPdERtSGk2am9aT1JTbHllUGhpRjZvVDNaVTJWcUxDUVplZXpLLXpOckd1T2ZGTmtIUkkwaG10ckxCN0tZZW1yaUtkX2h3UmdET0NBYw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2023-08-14T07:00:00.000Z",
    "time": "Aug 14, 2023",
    "articleType": "regular"
  },
  {
    "title": "Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting",
    "link": "https://news.google.com/read/CBMiwwFBVV95cUxOTTRQR25UdWN1RlMyazFpS2Q4TmRZOGhKZmhkZU11WXdCLXl1V3ByS2hpSlJtS3I5OEN5aklRQXhjUmNxUVpsaEZrQ1NSTFhseTN2a0ZNNVBQRXRaa09KSFg2WXZvcEQ2cVVrSXU2Y0JweVJ4bDR5dmwzWjF2bEIyTWgzQ01rNldER3czZHlxUm5vUnZNRHRSNk9Bb1ZCWlJXQUNQekZfS08zN2VJYXNtMmVod2dGV2ZwT2VxS0NoMEduYmM?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-03-05T08:00:00.000Z",
    "time": "Mar 5",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly adds ALS drug prospect with QurAlis deal",
    "link": "https://news.google.com/read/CBMiiwFBVV95cUxNOGJ0clBGRUJFcUpyMnhHQTFuZ3hsdm14czQ0QUdmV0YtSUVqaFRfckN2Znc3SDFRY2VvZDgyUmREU0l0c19jeGtYV0dqVWRKSXFQc2Y0MmNXMklzXzY2WTFJLUZhZlR2WjlYR2ZZZnpSODBhRlIxQWFhNnFsRFVTVlIzTU9ycktfNWtv?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXJYMFpIWDBndGVXMVRaM2xzVFJDb0FSaXNBaWdCTWdZQnRJek50UVk=-w400-h224-p-df-rw",
    "source": "BioPharma Dive",
    "datetime": "2024-06-03T07:00:00.000Z",
    "time": "Jun 3",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro",
    "link": "https://news.google.com/read/CBMidkFVX3lxTE82REpFa1VOTDVJY3B4WDhHb1FBQ1lrR1NZSlBMMlh0SG00QkZrZ2VuTkhvcDBpMW1BSHNuSVBLRThobjBCbWlRdml2Z2Nzd0ZFM2JfaHpWcmVwOFBWYUI4WFZ2MkRWUVpsWEpyUTZCNTNhZHNJSFHSAXtBVV95cUxNN0stdmFHNmpkYi0tZWtva0ZNTTZnNHA5MTV5N2Y5NEljNG1OUXUzUWhRR2g5QXJqOEhhUjUwNndyRUFRTV82RVltd3JWdEFFRVY5ZUU3QVZRaXo3aWtTcmNONTRjeWQwc2ZheElLRFg1MW9vUnNrTXB1aGM?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNTNVbXROY0cwelRIRnNhMHhNVFJDb0FSaXNBaWdCTWdZUlZaWUlJZ2c=-w400-h224-p-df-rw",
    "source": "CNBC",
    "datetime": "2024-04-30T07:00:00.000Z",
    "time": "Apr 30",
    "articleType": "regular"
  },
  {
    "title": "Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance",
    "link": "https://news.google.com/read/CBMiwgFBVV95cUxQTVFhTjJmSnR5UDk4SUNmLVBYTUc1MHVVbEtDdlo5Xy1aTEE5dWZNVm9wRGJLYzVuY1piemhyWWNKQlNjQ0ZJSkxFaWZWR0dLQTV5NGlidm82MmpUaUFra19mX0ZFTUZIU1ZzTmlDemtlcFpWakl6eVVELU9JWFFVekRUVWQ0OU1qd0ZUZlpxcGUwRGlVc3RMdUZRRXozQVpTaTdmYzJ4VDZmLXQ3YUt3UHNBRGNSMDd4a3lhWThnR2k4dw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-02-06T08:00:00.000Z",
    "time": "Feb 6",
    "articleType": "regular"
  },
  {
    "title": "Holcomb, Eli Lilly announce additional $5.3 billion investment in LEAP",
    "link": "https://news.google.com/read/CBMisgFBVV95cUxQc2NfRFo1VE5BeUVFLVFRS0Vvb29fUzJDb2RvNF82T1ZZTktHSmVhajVEbkpLN3RCaVlWR2tlZTZCVndaVmFJZHRWYjZ2dUNPMVRRVUJBRXpSM0w0VlE4WFFSUVZ5Y3ZRdzhvOVV2V1BRU1o3NWhfR2t2NTBHV3hmc2FMTXlRUExwTGJtaXVBekxFZ1IycWJZRmM3ZW1NMDZSUkFWelhNMnNGWFJBMGl1cC13?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNUJlRGxmVUU1dGJWTnJkblY2VFJDM0FSaVRBaWdCTWdZVk5JaXNGUW8=-w400-h224-p-df-rw",
    "source": "Indiana Capital Chronicle",
    "datetime": "2024-05-24T07:00:00.000Z",
    "time": "May 24",
    "articleType": "regular"
  },
  {
    "title": "Lilly's tirzepatide shows additional 21.1% weight loss after 12 weeks of intensive lifestyle intervention, for a total mean weight loss of 26.6% from study entry over 84 weeks",
    "link": "https://news.google.com/read/CBMivwFBVV95cUxNQXdMZGpISzVGYlFQX2JLTDVEdTU4WnRRcnVDR3RzS1JUSGQxdnd5VWVnTklnbFFmclU4RnNmRndESXJ0WXNtSFowT3lmdXBqbHJpdk8xWThoVkx2dnBvdHlxRG4wUE1zUHhLOXVjc1lVU2VJbVpNZ3IxaHBSell5aVhqX3RhQ3V6czRiazBYUG0wMUJleS1CVVA3S1BRUGloaXlVOVpMQl9xckp5RnRnUFZiQVdMeWJUc1pDOWM3bw?hl=en-US&gl=US&ceid=US%3Aen",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2023-10-15T07:00:00.000Z",
    "time": "Oct 15, 2023",
    "articleType": "regular"
  },
  {
    "title": "Melissa Seymour to join Lilly as executive vice president of Global Quality | Eli Lilly and Company",
    "link": "https://news.google.com/read/CBMivAFBVV95cUxOMDB1SG5taldZUmR5ZzBONmdlelFqSVZZcDB3UGNKRGhlb19wUC1iOUIxWWVISWoyMjFLcGN3amdJZWNVQVJmRjZGVnptTy1tRnJvZmlrS3FOOEYwRURsc1FuNG1nUWZTOUdWQjFpWUlOb3VpdHZ0dThfSWcwWUVDeENhQzVBc0R5bk9Ocl9jeWtxMDcwZGNjTGNqWm45MTBFaWEwWTR6VXlwOURka0E0ZDJaU1JwVzctNFFUZA?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-06-04T07:00:00.000Z",
    "time": "Jun 4",
    "articleType": "regular"
  },
  {
    "title": "Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference",
    "link": "https://news.google.com/read/CBMiwAFBVV95cUxNcFRTYVBJN2ZJSXlXMWRfVTRmN2hud1dTTmxBWE00eDlKWVFGNzdyZkljcnZtRDF6OVJ1Z0xnaF9uOE5Cd09QRFp3YUNlNUQzaDM5YnQxVk5fcWlMVE54eG5UM0hITnJtMlU3VVJUQmZ6ZkpQdlBtZnJudHJIbWdCQ1AwOTlfdlFXbkN2NjJLNEJqZTVtMi1Ma2JuZHFfNElxZ0d4a21LM2ViSlFQbHROZ3c3akx2WHYyVlJFZlJIeVo?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-05-28T07:00:00.000Z",
    "time": "May 28",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly warns about dangers of fake and counterfeit Mounjaro, Zepbound",
    "link": "https://news.google.com/read/CBMipgFBVV95cUxNbW5nUDJ1U1NsMG9aLS00X0U1QXJ3Z2FSd1pkZFJFdWxOeEFTMm1xTUpOdUl1SW94WmZVRURrbmZ3Q2hoN2ZlZGVtU0FjMTN0Rjdud1dCbVh6a2YwZjg2bDZfS1hMbzVndHRjZFVXZWs1R09KRGV2ZGY4cmxGb1luSlctT1o1LXVjQkRjSE1BV19jaWJZTm1TSmQ1TTZGeXktM3M0djlB0gGrAUFVX3lxTE9HYXN0eGFuR2xIQ2lERGhMVFNVUERpOTFPUnFINVU1OU1oTS1lVHFnZVhLbFpjRWZSR05LNVFVdUROZzFlbVZaaXc5c0FtMExraXdVVlgzdXRmWGhvTFZSX1pCZGtDY1NydExaQnlGMUtPQmtrRDBkOWpkcFFKVEhnTVBMa2xnanoyako1S2hTUDVRWUJiOWhxdy0tei1iWDhQbHk4TmhrLUROYw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNVNOVEZVV205aVVFMVBVMm93VFJDb0FSaXNBaWdCTWdZUlJaZ0lvZ2c=-w400-h224-p-df-rw",
    "source": "ABC News",
    "datetime": "2024-06-20T07:00:00.000Z",
    "time": "Jun 20",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly Wins FDA Nod for Obesity Drug That Rivals Wegovy, Ozempic",
    "link": "https://news.google.com/read/CBMiqgFBVV95cUxPNHdMeHo0Tkg2NnN4bVVGVlY1andEaWxpNjBDVXJ4UDQxemxmNU5MX195UnpLbjdsYWRqQl9oSjR0bUdSUnZidV9ZbS1Uc25Vamc3cXRueHlteklGNmRxQWhhLTlwVVN2bFZZdmxDaUxrVVV1aDdLRnJUbVgyMnl5Y3U1UzBpVVNlUk5mZ05uU3FHWVBoSGVHaGwzcENWb0VlWjNPeHU4cVlPZw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXRVVTlZYW0xeE0yeGtTSGMyVFJDb0FSaXNBaWdCTWdZVmM1QklyZ1k=-w400-h224-p-df-rw",
    "source": "Bloomberg",
    "datetime": "2023-11-08T08:00:00.000Z",
    "time": "Nov 8, 2023",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly: 2024 TIME100 Most Influential Companies",
    "link": "https://news.google.com/read/CBMiS0FVX3lxTE5tRnAxQ1hJcGNUMjgxLXAtLU92NllQOWVXMk1SenpNUjJmSTYwaVFiTVlsdm5VNXhkbGNlclgzZk5sQ2ktWUg3bnJzRQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNW9SMWROYm05WGFGWk5SRmx0VFJDM0FSaVRBaWdCTWdZVmNaSklNZ2c=-w400-h224-p-df-rw",
    "source": "TIME",
    "datetime": "2024-05-30T07:00:00.000Z",
    "time": "May 30",
    "articleType": "regular"
  },
  {
    "title": "Purdue joins Lilly at LEAP in pharmaceutical training facility",
    "link": "https://news.google.com/read/CBMitwFBVV95cUxNYW5xOGZJeHN3VzUwby1kWC11bGdrZHFoYU1ZbnhOUGVHMkZ4WkRFOG1ldFVKRFlfdmNJVXp6cU9Kb0VuUmtWcXUtaHZWYmpTY0NjaWFGNmJ5bGZLWTZtWlhLWXpSeUk5b3FoSHVVM0RtYzVNWHd2TEtrN0RHSDd6VGV6akxzOFdSZ096NGh2elIzd0F4MmQ1QjUxM1JJWVZmS3JlaVJ4RTAwTVNlWkhaY01mSm9qZ28?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNVpVMVV6YzBablpuVnFZVEYyVFJDM0FSaVRBaWdCTWdZVmNwSm9xZ2M=-w400-h224-p-df-rw",
    "source": "Purdue University",
    "datetime": "2024-05-28T07:00:00.000Z",
    "time": "May 28",
    "articleType": "regular"
  },
  {
    "title": "FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.",
    "link": "https://news.google.com/read/CBMijgFBVV95cUxPWFBlMG41MzlrQ0RPN3Zta0JSVndhOTlQZndVTHBFcWV2STgxY2FGVHJfRXpTSW90ZlBZX3lSNkgyYVFYbkJfLXVqaVd4OVgzSEZ6eFVDeDhCemV0bE1HVlBiRnJ0YVc5QkRVa1dzbjllRnd6bG41aHZDbjlxa2FEUWtPUXR2MjExaExhYTBB0gGTAUFVX3lxTE5fNXQxQTZxd0s4WTdvdm1fb2Y4NUZkVTh1MVB1UE1MVWNLeGlyQXFLbEJDS2VfYnRBZXVsal8tUnhqU3FMMzZEcU9NSldRcW13ZjhGU1NZVzBjR2o2U041em5Ga2pkeU15VlFqanVBSUNmcHBmOG9fczdIaEN4RXJFYW5BU0EyRGRLUFhJaFJCNEZzUQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNU1ZbEZZZUY5bU1sRkhlVTAyVFJDb0FSaXNBaWdCTWdZcEJvanR1UVE=-w400-h224-p-df-rw",
    "source": "CNBC",
    "datetime": "2024-07-02T07:00:00.000Z",
    "time": "Jul 2",
    "articleType": "regular"
  },
  {
    "title": "Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack",
    "link": "https://news.google.com/read/CBMixAFBVV95cUxOZnA4MzVpVnNIaThmX2REUlJ1TjhsczJJNUt2S2FER3NVODN2WTFXc19Qc1dEdmp0NXJzZGtQSjBoeGNLX2dNYkUtTy1TMWFwLURpTDFZVkJ5M0tIejVUZUhzRmtyVDZvcGkyeEkxb01wc2lHdzVvRzE2OHNCQTc1Wl91MDJLN3BhTk9MQm1VeG1yQTFjLTN4S0xEcV85NWNVZ20yZ2dJQUZMN3NORVBuTGFyUm14Nm1oNVBhRVlMWjdkeHZv?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-04-06T07:00:00.000Z",
    "time": "Apr 6",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug",
    "link": "https://news.google.com/read/CBMiqwFBVV95cUxNTzg2MUFNV1ZtQlNERlBCa0NVZjlTbGItSTRSS3RXdUlRWkpQYmx2WEEyRmF2Qkw2N080VzVsZHA0TDNHSUMxMHN6WjYyeEt6ZnpMT01uaUhObE5sZjFNZFU4cE0tY0lWMU5qZzZTQnczU1E4X0pXX2lLSGZIdmxvSFM4ZG1JOTdGVlF5YWhqWXJaUm5CeTJJSGJ4Mm1VcHJUWjNrVFlja2Q4WU3SAbABQVVfeXFMUGVmOXRhUnRlS29ZY1NjMGVGaGpOZHBEVWl0WDk5VFBfMzM1M0hiZ1hlRzc3SnNPNFFReFJJRHJ2bXFuMGFyeDduc1QzbnVDc2FtMnd6VGhEUTM4UGctSDJEUmIyLTY2Q0UtOEF6bWQtbGY2azN1ZXBvaDNfNTB3X0NzRXNQVmxKeWdGRmN5TVNaS0ZvenFoYV96SllPWmE0RjczNGZ4X08wZXlITTFLczE?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNTNPVFF4YjA5TE0xVjFWa2hNVFJDb0FSaXNBaWdCTWdZQkVvd01tZ28=-w400-h224-p-df-rw",
    "source": "CNBC",
    "datetime": "2023-09-19T07:00:00.000Z",
    "time": "Sep 19, 2023",
    "articleType": "regular"
  },
  {
    "title": "FDA approves Eli Lilly’s early Alzheimer’s treatment",
    "link": "https://news.google.com/read/CBMikgFBVV95cUxPSFZqUl83UnVPbHJZMGhSWjRLYWJtYW55S05YZXYybFlnNTFrbmxSUnZqaWkwcVB6bEFZdVlDSTQyZnVxb2hLYTk1czQ2b3JmLWtsMHU1NnRBak5nejQxazg0bUZzc1NfVVJTbU1YVktNUlFSa3djUDFPWVlzbGJ1ajFWZjJabTBwbmlBaGFOcm9YQQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHRhR05OWWtWcFdGUmZNM2RGVFJEaEFSamhBU2dCTWdZQnM0cHV0UVk=-w400-h224-p-df-rw",
    "source": "STAT",
    "datetime": "2024-07-02T07:00:00.000Z",
    "time": "Jul 2",
    "articleType": "regular"
  },
  {
    "title": "WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs",
    "link": "https://news.google.com/read/CBMipwFBVV95cUxNM2pUb3pwWWpKTEJjUHFMX3VuRnFrc3RYTjUxeXl1TGxjS042T0hjc0x1ZG1xa1JNeEV4TW51a0tjWUdEa2Zwa181ZW1LM2x0cExSMkxoUjZrcmhwN0Vzb1ZhMGVxNjlHUDdwM1lMQXJwODBhRTNtYUx3UXZxb0w1Y2dIcGRqdG41eHRYM0Y1NEdJd3RwME5nZTRQbGFaNXNYZHBsV0VHdw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iL0NnNTBabDlWTlVaSGVqSlllbTh4VFJDM0FSaVRBaWdCTWdtQmNaVEVybWMxekFF=-w400-h224-p-df-rw",
    "source": "The Associated Press",
    "datetime": "2024-06-20T07:00:00.000Z",
    "time": "Jun 20",
    "articleType": "regular"
  },
  {
    "title": "Fenwick Represents Morphic in its Acquisition by Eli Lilly",
    "link": "https://news.google.com/read/CBMipAFBVV95cUxOSXJOUVFVMWlGOVhBWkdNcndHbWIzY3dKN1pLZkNQV29SZVZTVVpvUW1GUXllZ1BrOHpyZkg4SzItVjd2Y3poSHJsaURLcGxZNzhVSFNuTGJIMUUtR2ExMTVMRUE3a1ZTaW5xT0Z1bVFsd2EzMEIwRGJMTTB0S2dPaUY1ODNEa0F0OS1kUlN5R3JXS0JYUWEzdnhheTkxUmN6NXlwSw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNTFlVWd0T0VGUFNqbDZSM2RoVFJDakFSaTJBaWdCTWdPSkRqdw=-w400-h224-p-df-rw",
    "source": "Fenwick & West LLP",
    "datetime": "2024-07-08T07:00:00.000Z",
    "time": "Jul 8",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly Surges On Strong Earnings As Mounjaro And Zepbound Sales Soar",
    "link": "https://news.google.com/read/CBMiwAFBVV95cUxOODNtdk91QmE3cXd1YzNyTXBLbVBWdVNtdFhXcW1GY3R6VVBUcjMteW9QQzFfQ2Q5Q1M2MXF4eHgzTXFSSVZwUkxHd1JGUko1SXZwLVpzTjROM05OWU9SZWhaYUNBb1pQNGtteEkzSExkS2FRX3ltUGZrOUhUZUF2d3ZlZDh6RUd0bklJYXV5S3AwVjdGd1g5OUxreW5ST1NJMkRkRkJnaTlvc3pMUFBDeHhVM0lLaEJ2czY0MFlOZUI?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNU9XV2hwWm04eWREUXlielJOVFJDb0FSaXNBaWdCTWdZSms0aXB2UVE=-w400-h224-p-df-rw",
    "source": "Forbes",
    "datetime": "2024-08-08T11:21:53.000Z",
    "time": "3 days ago",
    "articleType": "regular"
  },
  {
    "title": "Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work?",
    "link": "https://news.google.com/read/CBMijAFBVV95cUxON0tBYTZZWDVOOXducFlUalpXYWlkREYzWXJjbTEwYWdaRmtrZTJ0VU8yWTVVRnFMMUhWQzRmTWZBZkMyNF9MSlp1LUI1OHZXVllQNmUzV0kwb0tnT2xxVGVGRnVWSUpMWG1rbjVEMnA4c3R1LW42eVRwWkVVWW1NdUh4c2VwQzk0Q2Jtcg?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iL0NnNXRPSEl6Vmw4MmRIUk5ZMjQ1VFJDb0FSaXNBaWdCTWdrUk1vNHZyU1dLUndJ=-w400-h224-p-df-rw",
    "source": "BioPharma Dive",
    "datetime": "2024-05-22T07:00:00.000Z",
    "time": "May 22",
    "articleType": "regular"
  },
  {
    "title": "Your Story Matters",
    "link": "https://news.google.com/read/CBMiUkFVX3lxTFB0VmNCN18tVFRsYVNBa1RtNzBWcE9Qem1CZlBOLXJ1MEpCQVJzUkJWM2pVakRPQVFpQmpjMXFreXRWZ0tSNWNGbUFlb0I3dkFwQWc?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWlSbWRrTm1nMk1WWlNWVGRGVFJDUEFSamhBaWdCTWdheFZJNlFxUVk=-w400-h224-p-df-rw",
    "source": "Eli Lilly",
    "datetime": "2024-03-17T23:32:26.000Z",
    "time": "Mar 18",
    "articleType": "regular"
  },
  {
    "title": "The Next Potential Alzheimer’s Drug Clears a Big Hurdle",
    "link": "https://news.google.com/read/CBMibkFVX3lxTE1KWGFZTlFxRnptckNYOWdwQ05HN2xJSmRDVzZIVGdfLW55NlAzVnU0bmRoUWJVSmlpOTJIMlhrWUZHV0ZUU3dFSTRpZ1hSaXF2bTZjR1hqbkUtdmlSNmJMaUdyZjlDNDFtMURVSlRR?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNUJhME5VWjBrdGRWbDZNVGhWVFJDM0FSaVRBaWdCTWdhMUE1U1NrUXM=-w400-h224-p-df-rw",
    "source": "TIME",
    "datetime": "2024-06-11T07:00:00.000Z",
    "time": "Jun 11",
    "articleType": "regular"
  },
  {
    "title": "U.S. Food and Drug Administration Issues Complete Response Letter for Lebrikizumab Based on Inspection Findings at Third-Party Manufacturer",
    "link": "https://news.google.com/read/CBMivAFBVV95cUxOdzVmbGxOZ0p1dnE0NGxCSkFscHdLbEc4eEFRcTY2dkpzTHBjWTk4WEUyVzB4M0lFc0NVdGZqa0owNVNnZU01NTVfVFFPM1lMdVEyMXI0WGJhdEpHbnpfU2NSRnhlVWZ2REdCVE5keGtFX21qSWp6UFZmLVphOTVFRjVHbFpGTk01MU5CckhYZ3M3MWIxSTdzdEQyaHZwNkI1a1BZU0t6ZXQyZnNRVC1MX3MyMVhnX3VGdVJIdQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2023-10-02T07:00:00.000Z",
    "time": "Oct 2, 2023",
    "articleType": "regular"
  },
  {
    "title": "Lilly's Mirikizumab Helped Patients with Crohn's Disease Achieve Long-Term Remission in Phase 3 Trial",
    "link": "https://news.google.com/read/CBMiwgFBVV95cUxPWXA1T3J5UHUyeVJValh4d0hvcmJiUjEybWJhNnFJWV9RSVUycUp6RHdJS05udFdhN3N0NDhKdk82RUJfSC1uckE3VW5OTGxfcWVUUmxPV3djVkkzTC1FblFVaWhuendPUWRSaUpvX3lKQnF0M1FaWjdWdjBmVUQyYnNlQzVSOFR2RkhIeXpDVm5XUHl6VE1ZOHV2NFBiSFlTTDR1ZXh6aEVBRUpDVzdtNHpXZFBwdU8yQVlFa2RuemhMZw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2023-10-12T07:00:00.000Z",
    "time": "Oct 12, 2023",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly Alzheimer's drug approved by US FDA",
    "link": "https://news.google.com/read/CBMirwFBVV95cUxNRUZsSUp6ZkNLdUdjOTc1SDY0UExnS2dnMVJJWTM5N1BOc1pWWTdLMHd1akFFd0NBNThVTzlrOUtzbWxtb0dQNGpwZGFPUGZrZUZZVkhqeWRJVno3Wnpra3NubnpBMEplUHh5RGlIenFwSkhFZE1YT2Z1RnBMUGxaaXFmcmh2V2dFSks5c1c2Q1REenhOZDlOMG45dnk0NkJCaEl0Xy1QWUFiMVdHb1NV?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXpiRk4yY1hsMmR6WTBVR05xVFJDM0FSaVRBaWdCTWdhVkJJYnNpUXc=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-07-03T07:00:00.000Z",
    "time": "Jul 3",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly is attacking weight-loss drug knockoffs",
    "link": "https://news.google.com/read/CBMiigFBVV95cUxOQndjQ3ctNmJmQUdibE1KMjlrQUJpZzBoQmlDTU5GT2JOMXFObjV3MzRqX2RYaW1IYVI1VW1pZWpBaUtvZXhtcTEwUklfTi1zVmdiS0o3VU9HN29yOFUxOXR2NVg5RTNqd2xpLVYwS1hpWnVoYWM4T195TUFYYUtEY2VDTDltb19qYkE?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iL0NnNWpPVnBMYUdKTFZqSnBhRkUzVFJDb0FSaXNBaWdCTWdrdElZeHhGYWw3Y0FF=-w400-h224-p-df-rw",
    "source": "Axios",
    "datetime": "2024-06-20T07:00:00.000Z",
    "time": "Jun 20",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly CEO David Ricks on $.5.3 billion weight loss drug investment",
    "link": "https://news.google.com/read/CBMiwAFBVV95cUxQQmREUDY5SnhUbU8tSUtLTi1JQ1c2UFRQSk1YRHRIMFpXNVJHdTM4LUZrVjktejBudVcwTWNBU29hNWNuaUt3YTEydzhPWjVaWlE4TzFIdzJDeURuMmRrdDczRlNjMmhUd2N0RlMtb1Z0S1BaM1hScERnV1VoNFhDMzJPYkd3MVV4aXpiTWVnN19tUnJrMHJJMXZqNXJTMGl5bDdiVUlWbnFISlFRNXY3b1BFcFExUGpYcURmYWRwazQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iL0NnNVVOa3RuV0c1MFdFSk9WMUptVFJDb0FSaXJBaWdCTWdtSkVZYnZFS3VwU0FJ=-w400-h224-p-df-rw",
    "source": "CNBC",
    "datetime": "2024-05-24T07:00:00.000Z",
    "time": "May 24",
    "articleType": "regular"
  },
  {
    "title": "Lilly's Retevmo® (selpercatinib) Demonstrates Superior Progression-Free Survival Compared to Approved Multikinase Inhibitors in RET-Mutant Medullary Thyroid Cancer",
    "link": "https://news.google.com/read/CBMiwwFBVV95cUxNWFBFQW5rMmhqemNMdlNuNkhCVlJuMktuSTdwXzNMWllRQ0xJSkthRFJCWmVwMDR5bE1WQkphUGUxMGZORXFEVDN3clloNC1KX2s5R3BjRU9XQ3hBUkFfMG9OZkVQMjNFWnFJREhRUE41TTBsUG8zaWtqMGRPYnR2OTYtQWoxX0FxQnR2OWtfZUNoZmN6eWx5UU9vb0Flel9kVEpmYzZuMVVZR1pPT2dmNDBUYk1FQjJZd2d0QzFrVzc2WlE?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2023-08-22T07:00:00.000Z",
    "time": "Aug 22, 2023",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly settles whistleblower lawsuit over manufacturing problems",
    "link": "https://news.google.com/read/CBMirgFBVV95cUxOQnpNRERuWlVOenVKTW5CSnEyb0hhZDBvX1ExYXpRSHQwYW15eUVfb0t6dGhUX0o2RXRtbE93cXlfWi13ak1fR0drUmJ4UGFEUDFOMlNpeVNtQjhlZGNkVm10dGlNNnhnUTN2a3ZLTzl4czI1X1A3ZjR2SWN1WDNuUDZQbWdLWldBUXJicnFmNmZOal9TbmsyaVJCZkNhUnpfZ2lmRVgydENtYWhRakE?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXBlWFpYZW5kQ09XOUZlamd4VFJDM0FSaVRBaWdCTWdZZE00RnQyUUU=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2023-09-29T07:00:00.000Z",
    "time": "Sep 29, 2023",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs",
    "link": "https://news.google.com/read/CBMitgFBVV95cUxObE5EbHQ4dFlkR092NmdZSGs2QnJuX1dTekZfZVVpM0xDVUhuaVdkVW9uZFAwVkZSTEh1aFpGSUR2VE9GZE55a3JiTnFjSFlhYnd2WUxualFnUFBYYnFMSDJISGVvUGhLY2w1UEt4Wmd0M21IUUI4cktzb3AwTnZmTFRVUENPb0VWVklMdU1yd3lHeGJsTm16LWlOc2h5MEZySzVMTUZ1WXh1RFp1UThiemcwRlZIQQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNUxhRXR3TTNSaVIzRjBlaTB4VFJDM0FSaVRBaWdCTWdhUlU1UUlKZ2c=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-05-14T07:00:00.000Z",
    "time": "May 14",
    "articleType": "regular"
  },
  {
    "title": "FDA delays decision on Eli Lilly Alzheimer's drug, wants further review",
    "link": "https://news.google.com/read/CBMitAFBVV95cUxPVzJQTXpHU2M4RS02S29RUjEtWWlKcWg4anQxcGlERC0xX0wtWXd3aGxza1pUZUZrcEN1QnoyQ3BLc2lwNXEzbUxjcHFZUjQydDdFNlQ4RHJZQWdrR3h4TkdoV2xpeUM4MWZidmpXTHE3WVVPekZzUGpKanFrdVBZM2lpS0g1OVMwVWhHVmw0TVVRb3BGT0JnLWVHTlc2ODhjSGg5RjJrTTNIR193U1RzR2xHbUw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNTZUSEp3UVVwaGJFMVRjVVJPVFJDb0FSaXJBaWdCTWdZTnNJYm93UU0=-w400-h224-p-df-rw",
    "source": "Spectrum News NY1",
    "datetime": "2024-03-08T08:00:00.000Z",
    "time": "Mar 8",
    "articleType": "regular"
  },
  {
    "title": "Local statements on Eli Lilly acquisition of the Nexus Pharmaceuticals facility in Pleasant Prairie",
    "link": "https://news.google.com/read/CBMiZkFVX3lxTE01Smd1VDFNTzNIQUp1RU1RLUlDUEltbDJEN3ZNUzJWNmYzelVUYVlvSUZvemtEeVVjR2VSd045TXNKeTRlWkc2YjQ3SUFwTFp0ZUxIdmdXMkJSMmhrWHljek45TzdhZw?hl=en-US&gl=US&ceid=US%3Aen",
    "source": "Kenosha County, WI - Official Website",
    "datetime": "2024-04-25T07:00:00.000Z",
    "time": "Apr 25",
    "articleType": "regular"
  },
  {
    "title": "Alzheimer's: FDA approves Eli Lilly drug donanemab for amyloid plaques",
    "link": "https://news.google.com/read/CBMihwFBVV95cUxPLUU2ZmluMDQwTU03NEpmeDBHTkJXeGdrTGxnM3RuWExUVWhjdVNwbC1oXzFtV1FlQ3o5aWltQmVHQi0xMXFwTlNBOHRjY1ZJZ3BMSmJFNVhYOEZOTk8xU1V5eWtOTHhsRW9qNG9feUdYOTJockxZemlqcFM4U19oQnVGNXdDYzQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWpUa3hFTTFsb1VFNDRZMDVvVFJDb0FSaXNBaWdCTWdhQmdZZ3FSUVE=-w400-h224-p-df-rw",
    "source": "Medical News Today",
    "datetime": "2024-07-03T07:00:00.000Z",
    "time": "Jul 3",
    "articleType": "regular"
  },
  {
    "title": "How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut",
    "link": "https://news.google.com/read/CBMilgFBVV95cUxQT2Vfa3JZbWtycUJDaTZ6a2xudUVSQ291dUpockpWTkhLdVQ5Q3FQVXlJQVhBU0VtSmEzN2NyZkhxaXAxTHhMcnRDMVFSLVFhbkZxZHl0QWFIRkE2QXpfdXFLMkU5OXJMSW5mTWJEWUJpdnlPYUpaZnFVc3liMWVXYzRIeUlZLTc0RFlSZEl3aERXYTAzdVE?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iJ0NnNU1UVmRhVFZsa2JrOXdaMHBEVFJDM0FSaVRBaWdCTWdNUnhRQQ=-w400-h224-p-df-rw",
    "source": "Fortune",
    "datetime": "2024-08-02T07:00:00.000Z",
    "time": "9 days ago",
    "articleType": "regular"
  },
  {
    "title": "US FDA says all doses of Lilly's weight-loss and diabetes drug are now available",
    "link": "https://news.google.com/read/CBMi1wFBVV95cUxPZi1Uc0VRdXpYQWlQaC14RkJCMVVzVGlLMnNodkM4amduN3NPc010V0ZWV1pxZ2JMMVN6MTl6NlU0WWNlZmg0Q2dIWGhuaGZlMTdKM0dOLXR0ME1UMFE1aERKWmE3c2drSlpPbl9NZ2Z3bVQ3clgzMUJyNzhWaTZyN3p3RmJidktpX3lkUXJhTUttdllqYjZacS1oRFpKMmdfOTR1VXdMUmV6TXZZTV9WUWMwWnJIUkJVU0M1RWQ0eEE2LXlZa1BMMXpCWXFkNmZUSV8tcUY1UQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNDBjRFF5U21sR1ZIVlNUazR0VFJDM0FSaVRBaWdCTWdhUlZKUUlKZ2c=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-08-02T07:00:00.000Z",
    "time": "9 days ago",
    "articleType": "regular"
  },
  {
    "title": "Aktis to collaborate with Eli Lilly on cancer therapies",
    "link": "https://news.google.com/read/CBMivgFBVV95cUxNdmlVWEVXZmEtTU5RdHc1dUtPT2N4dDZ5VFpsQ2FXSm9XUzE3TGpuR055eHhKZkhxOXg1OUVTS2NyMmRJQUFYZE4yYzBIcGhVVmpMYkdRQWFQM1NpQ3dlcFdzZFROc2RrODkzeXd3X1RjMGUzQVhtY3Q2WmgxbF9YMXZfT2lGYl83Q2FFU2VYMDVDZWxDNWJYSVZVbHNKMmhnY0hncHFUamJiV3dqanZxMGJNVkRvbzJMRFZ5OWlR?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNTJNRkZOYlhablMxWndjMk5VVFJDM0FSaVRBaWdCTWdhcFk1aE9KUWc=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-05-21T07:00:00.000Z",
    "time": "May 21",
    "articleType": "regular"
  },
  {
    "title": "How a Lucky Break Fueled Eli Lilly’s $600 Billion Weight-Loss Empire",
    "link": "https://news.google.com/read/CBMivAFBVV95cUxOUE15d0hobkdVeG1OczhxSGMwUUJuTlRMSHNfcUtLS2R0TWpEQlZtbUlvZGxURlBZb0FPWWppcWtjRzJURmxxZ0JPQWpqNFJKMTNaMGthNmJFQWtZd2dpcHBhOUtQek9zeGpQQVRqaHl3RTJNWUFmcHN0NlBSNHZHWUN5OWNZY2NBTnNnbEd1X205YkJWY2xwRVJFeTdaZVZITUZ2OW1Nd005c1R5emljODdfb3hsQ0w1N0NDXw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iMkNnNVBja1pvT1haNlVTMTBPV05UVFJEOEFSaklBU2dCTWdzQklZUXNuU0tpWjRvUE5R=-w400-h224-p-df-rw",
    "source": "Bloomberg",
    "datetime": "2024-01-25T08:00:00.000Z",
    "time": "Jan 25",
    "articleType": "regular"
  },
  {
    "title": "FDA approves a second Alzheimer’s drug that can modestly slow disease",
    "link": "https://news.google.com/read/CBMiowFBVV95cUxQbXlFSEUxREx5aGpPSTdqLTZKWHlwRzZYdUZybzNNLVNZdkJoTUcwZEdycG9JZ20yazlXUWRuOXpKRGhpZlU4RDJtSmtQYnBaUTl4b3pjdWtFbnNqNDVuN2JmRjVUM1czS1gtS3BKSmJBTmdBNXg3V0dXZDZsRHZoMkhlVjREVmk0Q1JHNEFWQklDVktNaUpRR1NSc09NR2M5UGJ3?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWxkRlZqVlVOalFrNVhjREUzVFJDM0FSaVRBaWdCTWdZdE5vcnVOUVU=-w400-h224-p-df-rw",
    "source": "The Associated Press",
    "datetime": "2024-07-02T07:00:00.000Z",
    "time": "Jul 2",
    "articleType": "regular"
  },
  {
    "title": "Lilly beefs up bowel disease drug portfolio with $3.2 bln Morphic deal",
    "link": "https://news.google.com/read/CBMimgFBVV95cUxQaHJMcmtMQVFRT3gzR1FuT3VpWjF4aG8xblZJby1NdDF2Z2otWVl1YU9lQ2FzaHFUb0plMEVJRDNyQzRDcEVFeTBEY1JyUDlJX2JMV0dUWHhkdEhBZmVlUWFfdXhzdGtLN0tFdl9DNmRFSEZDYUJ5S0prSFZxdUx5NzNDWkdVdzZqSUJzNFJOS3V1NVRabGxqZXF3?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNUxhRXR3TTNSaVIzRjBlaTB4VFJDM0FSaVRBaWdCTWdhUlU1UUlKZ2c=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2024-07-08T07:00:00.000Z",
    "time": "Jul 8",
    "articleType": "regular"
  },
  {
    "title": "Lilly Statement on Mounjaro® (tirzepatide) Compounding Litigation | Eli Lilly and Company",
    "link": "https://news.google.com/read/CBMivwFBVV95cUxQcjdITXRlNjhjd0MwUGFQc3V4WFl6a2dpeFE1dTVWZlM5ZnR4LW1zYUpoY2dGaFlmVnlSV1ZqbXMwMldKNjJfaEJxUzJlTnQwNW05UFROd3oyeUU5WEFTb2FmMjdXTUJhT1N0RXlydUluUlB0WUkwTjZndzFyeGtTSm5IOG04V1prd3pSaWFvMjdUWVRkMmpIa2FMZl9lYWF5OG1ZTXVEc1EycTNBRFVmOFRGZ3VnT0gzdzdkd2c5MA?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2023-09-19T07:00:00.000Z",
    "time": "Sep 19, 2023",
    "articleType": "regular"
  },
  {
    "title": "Will The Supply Shortage Weigh On Eli Lilly’s Q2?",
    "link": "https://news.google.com/read/CBMiqgFBVV95cUxPMExzOUJQODM5aS1NRmkyMGQ1TFFSaFBaa0ljblA3bllZa0VwLXkxb19TWVc1ZjA2ME1WMkVsVFhJLWtXdXA5dHQwc21iRnZ2UEVUekxhemMwc2xLYkVyZUo4LVBaSjEzQUc2b3lPYUphYzIzdW1GejZFTUlPQW9RQWQtUmlrcDlmOWt3U3JUaXBtenJWYk9xOEV6WEEydFFXb0RpSm9tc1gwQQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXlTMWxhZW14UWVrRkdlbTU0VFJDMkFSaVdBaWdCTWdZcGRZeXRyUWM=-w400-h224-p-df-rw",
    "source": "Forbes",
    "datetime": "2024-08-06T14:00:23.000Z",
    "time": "5 days ago",
    "articleType": "regular"
  },
  {
    "title": "Lilly Update on Mounjaro® and Zepbound® (tirzepatide) Compounding Litigation | Eli Lilly and Company",
    "link": "https://news.google.com/read/CBMivwFBVV95cUxQbXIzc0lsSmtOT053YXA1V19BbHA5SHp0NUZyZUJBWHgxejFqMEpKYXdHUGxTSDhQelNVXzJXUGVsSVdVUW9VYkxpejhINGdMb3RLQmJ2UkFBbGQxSFI5U254WjBJSDBNZXliYlQ3VVlzUlAzakJza0xWaEQ5OE4xYWhjblhHYWZZRmJSQXNHbXIwOXZwNFlTUVBwcTlvQ0hpSEJpS3p3TXJZUWYxOUxhZC1IYWpubGZKVFNfWkk3NA?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2024-05-14T07:00:00.000Z",
    "time": "May 14",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly’s partnership with Amazon to boost presence in diabetes and obesity markets",
    "link": "https://news.google.com/read/CBMi2gFBVV95cUxNTFdSQWJmWC0xMGplbmc4NUZSSEg4NTY3dDE5VVBNaWFueW5GY3ZPVTJYSkVMLUNhZktucXdCOHdIZ3F5cVBUdmtqU0ZpN1NGLTU2WU9zQndERldYOW1IQi1rYmhUS1h2cldQTEhxendkamR3cE10MGM5eEMzVGlKbUt5Q3ZleV9kYzJCUzZRbnk0UEJ5T2RzbzZTM21vb0NlMWJiYlVjanNMQVZGanNKNDRKZldnbi1sU1VOZUJUV0VjTndPUnVyYVhncTRPM0dERVVDQ29JX2FtUQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNWFMVlZFTUhwNU5UWnpjWHBTVFJDM0FSaVRBaWdCTWdhUlVaSktwUWM=-w400-h224-p-df-rw",
    "source": "Pharmaceutical Technology",
    "datetime": "2024-03-19T07:00:00.000Z",
    "time": "Mar 19",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly Gets Green Light To Sell Weight-Loss Drug in China",
    "link": "https://news.google.com/read/CBMingFBVV95cUxQZWZHTXNQZGUyOFFEYXktVV9OSWdUczhzUzR0V1BIdzYwenRzQ1g4bzZjWnk3Ykl0ajBhcjM4Y0l1OUEtWVI4NXBBNmotUlFMcXhUcGdJREtGWmhFbEpCdVNaSERCZ0tySVdNREJxTGRYVjEwaTYtSnNTTHN3MG5SR0QwUTdpdUhzNHl2bVE0WVNmZ2xaM2JvWGV5TGRydw?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iI0NnNVljSEI1TFhWYWFXZDRPVWxJVFJDM0FSaVRBaWdCTWdB=-w400-h224-p-df-rw",
    "source": "Investopedia",
    "datetime": "2024-07-19T07:00:00.000Z",
    "time": "Jul 19",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly lifts sales guidance by $3B as supplies of Mounjaro and Zepbound recover",
    "link": "https://news.google.com/read/CBMipAFBVV95cUxNSzlPelBGVkRna29IWmRsWG1sUVFOb0FrNzMtSmFKa2VvMmw1alhCdWE1TE5WbExWdHdMNHo5SFZDZUp2WUNlY2hnLWpMQ0JKcEtQTmFRaldRQkQwQVNmTklPa3ZWMWtQMm56Y2NidU5KQm4xWmNiTEkzUXhvcEtfdnY1a2hlRHVuZmxaemFCcEhvcno3UmVMdUhXalZ6QWRnODhUZQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNXRNbFpHYjFGVGNVMTNURzlpVFJDb0FSaXNBaWdCTWdhcFZaTE5KUWc=-w400-h224-p-df-rw",
    "source": "FiercePharma",
    "datetime": "2024-08-08T15:18:37.000Z",
    "time": "3 days ago",
    "articleType": "regular"
  },
  {
    "title": "Eli Lilly sues over US sales of bogus Mounjaro for weight loss",
    "link": "https://news.google.com/read/CBMingFBVV95cUxOTF9wN2FNSzR1cVhiR0lxc3UwUUx2M3JSanp6dkhXOUwzSEJjenhMUG8wNWR0b25JMnlRM2VBbnFMbXkwWXFFZk9VbUJ6OGRQcy04c3MxYmhfblpxOWFZZ0tVYjg1NG5ZSzhjTG1SUTlCaU9sWDhnVTdmenVhcTdfRGsxMmJvWWQ0NmU1R3FxZm43cHo4dHpwV09uSUdzUQ?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNVRlaTF0WW14RVVUSlRkR3h4VFJDM0FSaVRBaWdCTWdhTlU1TEZvZ2s=-w400-h224-p-df-rw",
    "source": "Reuters",
    "datetime": "2023-09-19T07:00:00.000Z",
    "time": "Sep 19, 2023",
    "articleType": "regular"
  },
  {
    "title": "Lilly's Zepbound™ (tirzepatide) achieved additional 6.7% weight loss following a 36-week open-label lead-in period, for a total mean weight loss of 26.0% from study entry over 88 weeks",
    "link": "https://news.google.com/read/CBMixAFBVV95cUxQcFFzWFBRVXdNSjVHenJkNnBobUVIX3RfelROLXN0d2ZpT1oxNUhTVFgyZmczdVZoYzhHaGg3OEVuNVZ1ZGoyYTF0MEtiQU13bzhqajBNTWIzeEQxZzBvNEJjeTV3TjV6LWc5QjZIRW1BUzBKa1MzMlBzOXE2SlJ1cksySmhRLUJnalV5RHJ5dVlZd21odlAwUklDSEx5RHh2TjlDSWw1bWhuaDd5cEdfTnVOdDRrQ0N0cTdMeVJNV0Nxbko1?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iK0NnNHlORjltTkdoa1lsVlRPVVJIVFJDUEFSamhBaWdCTWdhQkdJcUhGZ2s=-w400-h224-p-df-rw",
    "source": "Investors | Eli Lilly and Company",
    "datetime": "2023-12-11T08:00:00.000Z",
    "time": "Dec 11, 2023",
    "articleType": "regular"
  },
  {
    "title": "Weight-Loss Drugmaker Eli Lilly Is Gearing Up for the Olympics",
    "link": "https://news.google.com/read/CBMizAFBVV95cUxNTG5IMGNxUzJ4V2RPeVBRSzBfcTQ1TGFrVXZ4a3hRaXdUclA0SGhQT0M3cVE4ZVdvVUlrVVNVYzFhOEhibHdMV0pFSkt3b2NOTXZDbHAwYy1Xd1cycGM4Q0xneFRXRVN4YmNZVnBmbE52N1RpZWx6N3FXdTNqWWdrZVNpWnd6eC12aGQ5bXc1RGg1d0tCb3lnR3NsalpUUHlWVzJLUGpldHd1MzFkZ1pGQzJ6U2FsR09tSkREdk50dmRodkFUMXAtOFdtckM?hl=en-US&gl=US&ceid=US%3Aen",
    "image": "https://news.google.com/api/attachments/CC8iL0NnNXdVRVpCVEdwV05UWnpXVFpaVFJDM0FSaVRBaWdCTWdtQjBZYWwwbU5VVXdF=-w400-h224-p-df-rw",
    "source": "Bloomberg",
    "datetime": "2024-06-06T07:00:00.000Z",
    "time": "Jun 6",
    "articleType": "regular"
  }
]